Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medical System Network Co., Ltd. ( (JP:4350) ) has shared an announcement.
Medical System Network reported consolidated net sales of ¥98.7 billion for the nine months ended December 31, 2025, a 7.4% year-on-year increase, but profitability weakened, with EBITDA down 3.5%, operating profit down 7.8%, ordinary profit down 14.0% and profit attributable to owners of parent dropping 30.1% to ¥1.01 billion, leading to a decline in earnings per share to ¥34.56. The company’s balance sheet expanded, with total assets rising to ¥82.3 billion and net assets to ¥17.1 billion though the equity ratio softened to 20.6%, and management kept its full-year 2025/26 earnings and dividend forecasts unchanged, signaling confidence in achieving modest full-year growth in sales and profits despite margin pressure in the first three quarters.
The most recent analyst rating on (JP:4350) stock is a Buy with a Yen580.00 price target. To see the full list of analyst forecasts on Medical System Network Co., Ltd. stock, see the JP:4350 Stock Forecast page.
More about Medical System Network Co., Ltd.
Medical System Network Co., Ltd. is a Japan-based company listed on the Tokyo Stock Exchange that operates in the healthcare-related services sector, with a business model centered on medical and pharmaceutical support services. The company focuses on generating stable recurring revenue in Japan’s medical system value chain, positioning itself as an infrastructure player supporting pharmacies, medical institutions and related stakeholders.
Average Trading Volume: 35,236
Technical Sentiment Signal: Buy
Current Market Cap: Yen15.87B
See more insights into 4350 stock on TipRanks’ Stock Analysis page.